NADAL® Nuclear Matrix Protein 22 Test

Product overview

• Qualitative detection of NMO22 in urine samples
• Rapid test for bladder cancer screening
• Test result can be read after approx. 15 minutes
• Simple visual interpretation without additional devices
• 10 test cassettes and 10 disposable pipettes

Guaranteed usable until: 30/07/2026

NADAL® Nuclear Matrix Protein 22 Test

The NADAL® Nuclear Matrix Protein 22 (NMP22) Test from Nal von Minden is a dependable in-vitro immunoassay for qualitatively detecting Nuclear Mitotic Apparatus Protein (NuMA) in urine. This professional quick test provides doctors with a simple and hygienic way for bladder cancer screening and surveillance, with results available in roughly 15 minutes.

Product Details

• NADAL® Nuclear Matrix Protein 22 from nal von Minden
• Reliable and hygienic in-vitro immunoassay
• Qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA)
• Professional rapid test for bladder cancer screening
• Applicable for monitoring as well
• Sample material: Urine
• Detected parameter: Nuclear Matrix Protein 22
• Results readable in about 15 minutes
• Simple visual interpretation without additional devices
• Includes integrated procedural control
• Storage at room temperature (2-30 °C)
• CE marked
• Includes 10 disposable pipettes and a user manual
• 10 tests